Get the Stockscreener App
52.46
3.28%
1.87
Bright Minds Biosciences Inc stock is traded at $52.46, with a volume of 377.09K.
It is up +3.28% in the last 24 hours and up +4,404% over the past month.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
See More
Previous Close:
$50.59
Open:
$50.5
24h Volume:
377.09K
Relative Volume:
0.13
Market Cap:
$243.90M
Revenue:
-
Net Income/Loss:
$-4.98M
P/E Ratio:
-27.03
EPS:
-1.9408
Net Cash Flow:
$-3.85M
1W Performance:
+16.06%
1M Performance:
+4,404%
6M Performance:
+5,178%
1Y Performance:
+3,858%
1-Day Range:
$50.50
$58.00
1-Week Range:
$40.94
$58.00
52-Week Range:
$0.93
$79.02
Bright Minds Biosciences Inc Stock (DRUG) Company Profile
Name
Bright Minds Biosciences Inc
Sector
Industry
Phone
-
Address
-
Bright Minds Biosciences Inc Stock (DRUG) Latest News
Bright Minds Biosciences Closes US$35 Million Non-Brokered Private Placement - ForexTV.com
Bright Minds Biosciences Closes US$35 Million Non-Brokered Private Placement - GlobeNewswire Inc.
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In October 2024 — Where Do Tesla, Nvidia, Apple, DJT Stock Rank? - Benzinga
Top 4 Canadian Biotech Stocks of 2024 - Investing News Network
Bright Minds Biosciences: BMB-101's Phase 2 Trials Could Unlock Epilepsy Market Potential - Seeking Alpha
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.47% - MSN
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Short Interest Up 1,274.9% in October - MarketBeat
Steven Cohen's Strategic Acquisition of Bright Minds Biosciences Inc Shares - GuruFocus.com
Rivian Automotive Inc (NASDAQ: RIVN): Blank Check On Growth? - Stocks Register
Logos Global Management LP Acquires New Stake in Bright Minds Bi - GuruFocus.com
Bright Minds rebounds after $35M private placement - MSN
Soaring $1-handle stocks leaping into IBKR’s most-active list may point to market froth - MSN
Cormorant Asset Management's Strategic Acquisition of Bright Minds Biosciences Shares - Yahoo Finance
Cormorant Asset Management's Strategic Acquisition of Bright Min - GuruFocus.com
Bright Minds Stock Skyrockets After $35M Private Placement Amid Volatility - SpeaksLY
$DRUG 5,900% Weekly Surge Turns Attention. Cybin ($CYBN) Rallying 23% This Week In Anticipation For Major Milestones - FinanceFeeds
Bright Minds Biosciences (DRUG) Partners with Firefly Neuroscience, Resulting in Stock Surge - TipRanks
Bright Minds and Firefly Neuroscience Renew Collaboration - TipRanks
What's Going On With Bright Minds Biosciences Stock? - Benzinga
Such Is The Power Of Bright Minds Biosciences Inc (NASDAQ: DRUG) - Stocks Register
Cigna and Humana re-engage in merger talks - Yahoo! Voices
Gen Z demands improved payment options for insurance in UK - Yahoo! Voices
2 Artificial Intelligence (AI) Stocks That Could Make You a Millionaire - Yahoo! Voices
Bright Minds, Firefly Neuroscience Shares Rise on Collaboration for Clinical Trial Analysis - MarketWatch
Bright Minds, Firefly Neuroscience to collaborate after BREAKTHROUGH study - TipRanks
Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG Data - The Manila Times
Netflix's Third-Quarter Results Exceeded Expectations. But Is the Stock a Buy? - Yahoo! Voices
In data: Value, luxury, sportswear set to drive Turkish apparel market - Yahoo! Voices
Fuzzy’s Taco Shop announces new leadership roles - Yahoo! Voices
SB Energy’s Orion Solar Belt begins commercial operations in US - Yahoo! Voices
KIMS signs MOU with Wipro GE Healthcare for medical technologies - Yahoo! Voices
Nordic and BeeKeeperAI partner to accelerate AI clinical support systems - Yahoo! Voices
DNB Bank acquires asset manager Carnegie - Yahoo! Voices
Groww pays $160M tax as it returns to India amid a startup relocation wave - Yahoo! Voices
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.75% - MSN
FDA is said to see “path forward” for ecstasy-based drug (DRUG:NASDAQ) - Seeking Alpha
Extra Space Storage Inc. stock outperforms competitors on strong trading day - MarketWatch
Ross Stores Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Bright Minds Biosciences’ $35M Private Placement Boost - TipRanks
Bright Minds Bio soars on US$35M private placement; up 5,400% in 5 days - Mugglehead
Crude Oil Down Over 1%; American Express Shares Fall After Q3 Results - Benzinga
Nashville Convention Center Authority board members confirmed for second term overseeing Music City Center - Yahoo! Voices
What's Going On With Bright Minds Biosciences Stock Friday? - Benzinga
Bright Minds’ stock explodes after $35M placement, pain drug news - Green Market Report
(DRUG) Investment Analysis - Stock Traders Daily
Bright Minds Biosciences Shares Surge 70% on $35M Private Placement - MarketWatch
Insider Trading Recap: Thursday's Top Buys and Sells in US Stocks - Investing.com Canada
Insider Trading Recap: Thursday's Top Buys and Sells in US Stocks By Investing.com - Investing.com South Africa
Bright Minds Biosciences Stock Back In Retail’s Spotlight With $35M Funding Round Via Private Placement - Barchart
Bright Minds stock gains post-private placement (DRUG:NASDAQ) - Seeking Alpha
Pα+ Psychedelic Bulletin #177: Bright Minds Surges on Longboard’s Seizure Drug Success; Kasvu Therapeutics Is Developing Psychoplastogens With a TrkB Twist - Psychedelic Alpha
Bright Minds Biosciences Inc Stock (DRUG) Financials Data
Revenue
Net Income
Cash Flow
EPS
Bright Minds Biosciences Inc Stock (DRUG) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Cormorant Asset Management, LP | 10% Owner |
Oct 16 '24 |
Buy |
23.46 |
50,000 |
1,172,813 |
875,000 |
1.75%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):